Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:focusesOn |
protein therapeutics
|
| gptkbp:foundedIn |
2014
|
| gptkbp:founder |
gptkb:Floyd_Romesberg
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Synthorx
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:THOR-707
|
| gptkbp:parentCompany |
gptkb:Sanofi
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:researchArea |
oncology
immuno-oncology |
| gptkbp:stockSymbol |
gptkb:THOR
|
| gptkbp:technology |
expanded genetic alphabet
|
| gptkbp:website |
https://www.synthorx.com/
|
| gptkbp:bfsParent |
gptkb:Synthorx_(2019)
gptkb:Floyd_Romesberg |
| gptkbp:bfsLayer |
7
|